Tecogen Inc.
TGEN
$2.20
-$0.20-8.33%
| Weiss Ratings | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.65 | |||
| Price History | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 21.28% | |||
| 30-Day Total Return | -25.17% | |||
| 60-Day Total Return | 25.00% | |||
| 90-Day Total Return | 138.10% | |||
| Year to Date Total Return | 41.94% | |||
| 1-Year Total Return | 214.29% | |||
| 2-Year Total Return | 105.61% | |||
| 3-Year Total Return | 50.68% | |||
| 5-Year Total Return | 15.79% | |||
| 52-Week High % Change | -29.41% | |||
| 52-Week Low % Change | 310.26% | |||
| Price | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.40 | |||
| 52-Week Low Price | $0.59 | |||
| 52-Week Low Price (Date) | Apr 22, 2024 | |||
| 52-Week High Price (Date) | Feb 05, 2025 | |||
| Valuation | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 59.88M | |||
| Enterprise Value | 62.30M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.23 | |||
| Earnings Per Share Growth | 32.09% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.66 | |||
| Price/Book (Q) | 5.28 | |||
| Enterprise Value/Revenue (TTM) | 2.78 | |||
| Price | $2.20 | |||
| Enterprise Value/EBITDA (TTM) | -13.23 | |||
| Enterprise Value/EBIT | -11.90 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 24.85M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 781 466 6400 | |||
| Address | 45 First Avenue Waltham, MA 02451 | |||
| Website | www.tecogen.com | |||
| Country | United States | |||
| Year Founded | 2000 | |||
| Profitability | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -23.33% | |||
| Profit Margin | -24.15% | |||
| Management Effectiveness | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -11.55% | |||
| Return on Equity | -- | |||
| Income Statement | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 22.44M | |||
| Total Revenue (TTM) | 22.44M | |||
| Revenue Per Share | $0.90 | |||
| Gross Profit (TTM) | 9.49M | |||
| EBITDA (TTM) | -4.71M | |||
| EBIT (TTM) | -5.24M | |||
| Net Income (TTM) | -5.42M | |||
| Net Income Avl. to Common (TTM) | -5.42M | |||
| Total Revenue Growth (Q YOY) | -20.84% | |||
| Earnings Growth (Q YOY) | -100.34% | |||
| EPS Diluted (TTM) | -0.23 | |||
| EPS Diluted Growth (Q YOY) | -100.00% | |||
| Balance Sheet | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.28M | |||
| Cash Per Share (Q) | $0.05 | |||
| Total Current Assets (Q) | 18.17M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 11.19M | |||
| Current Ratio (Q) | 1.534 | |||
| Book Value Per Share (Q) | $0.45 | |||
| Total Assets (Q) | 27.48M | |||
| Total Current Liabilities (Q) | 11.84M | |||
| Total Debt (Q) | 3.81M | |||
| Total Liabilities (Q) | 16.29M | |||
| Total Common Equity (Q) | 11.30M | |||
| Cash Flow | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -796.00K | |||
| Cash from Financing (TTM) | 1.35M | |||
| Net Change in Cash (TTM) | 636.10K | |||
| Levered Free Cash Flow (TTM) | 668.10K | |||
| Cash from Operations (TTM) | 79.90K | |||
